WP
ANAB icon

Woodline Partners’s AnaptysBio ANAB Stock Holding History

Woodline Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.4M Buy
717,014
+372,758
+108% +$22.6M 0.15% 181
2026
Q1 		$19.1M Sell
344,256
-156,767
-31% -$8.43M 0.07% 353
2025
Q4 		$24.3M Hold
501,023
– – 0.09% 271
2025
Q3 		$15.3M Hold
501,023
– – 0.07% 338
2025
Q2 		$11.1M Sell
501,023
-290,000
-37% -$6.07M 0.06% 408
2025
Q1 		$14.7M Buy
791,023
+305,950
+63% +$5.1M 0.1% 285
2024
Q4 		$6.42M Buy
485,073
+25,094
+5% +$608K 0.04% 434
2024
Q3 		$15.4M Buy
459,979
+207,613
+82% +$7.09M 0.13% 223
2024
Q2 		$6.32M Sell
252,366
-256,473
-50% -$5.97M 0.06% 312
2024
Q1 		$11.5M Sell
508,839
-686,135
-57% -$16.2M 0.11% 240
2023
Q4 		$25.6M Buy
1,194,974
+354,153
+42% +$6.11M 0.28% 112
2023
Q3 		$15.1M Sell
840,821
-193,728
-19% -$3.7M 0.18% 164
2023
Q2 		$21M Buy
1,034,549
+574,987
+125% +$11.7M 0.25% 114
2023
Q1 		$10M Sell
459,562
-187,983
-29% -$4.57M 0.14% 199
2022
Q4 		$20.1M Sell
647,545
-462,617
-42% -$13.1M 0.27% 105
2022
Q3 		$28.3M Buy
1,110,162
+189,524
+21% +$4.44M 0.4% 68
2022
Q2 		$18.7M Buy
920,638
+86,711
+10% +$1.92M 0.29% 109
2022
Q1 		$20.6M Buy
833,927
+223,946
+37% +$6.78M 0.33% 88
2021
Q4 		$21.2M Sell
609,981
-403,975
-40% -$12.8M 0.3% 88
2021
Q3 		$27.5M Buy
1,013,956
+473,904
+88% +$12M 0.45% 57
2021
Q2 		$14M Buy
540,052
+111,205
+26% +$2.67M 0.26% 102
2021
Q1 		$9.24M Buy
+428,847
New +$10.8M 0.21% 124

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodline Partners's ANAB Position: Q2 2026 in Review

Woodline Partners increased its AnaptysBio (ANAB) stake by 108% in Q2 2026, buying an estimated $22.6M and bringing the position to 717,014 shares worth $48.4M. The position accounts for 0.15% of the portfolio, ranked #181.

Woodline Partners first reported a position in ANAB in Q1 2021 and has held it in 22 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Woodline Partners held 717,014 shares of AnaptysBio worth $48.4M as of Q2 2026.
  • Woodline Partners bought 372,758 AnaptysBio shares in Q2 2026, an estimated $22.6M.
  • AnaptysBio made up 0.15% of Woodline Partners's portfolio in Q2 2026, its #181 holding.
  • Woodline Partners first reported a position in AnaptysBio in Q1 2021 and has held it in 22 quarters since.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.